LINC00853 has been reported to regulate the level of CC chemokine receptor 9 (CCR9) modulating the binding of CCR9 and CC chemokine ligand 25 (CCL25), which was involved in the process of the infiltration of T cell acute lymphoblastic leukemia [27]. Here, CCR9 is linked to T-cell acute lymphoblastic leukemia.